000			02120 a2200577 4500
005			20250515171629.0
264		0	_c20090730
008			200907s 0 0 eng d
022			_a1574-8863
024	7		_a10.2174/157488609788173035 _2doi
040			_aNLM _beng _cNLM
100	1		_aCapasso, Anna
245	0	0	_aFunctional interaction between purinergic system and opioid withdrawal: in vitro evidence. _h[electronic resource]
260			_bCurrent drug safety _cMay 2009
300			_a97-102 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdenosine _xanalogs & derivatives
650	0	4	_aAdenosine A1 Receptor Agonists
650	0	4	_aAdenosine A1 Receptor Antagonists
650	0	4	_aAdenosine A2 Receptor Agonists
650	0	4	_aAdenosine A2 Receptor Antagonists
650	0	4	_aAdenosine Triphosphate _xanalogs & derivatives
650	0	4	_aAnalgesics, Opioid _xpharmacology
650	0	4	_aAnimals
650	0	4	_aCaffeine _xpharmacology
650	0	4	_aDipyridamole _xpharmacology
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aGuinea Pigs
650	0	4	_aIleum _xdrug effects
650	0	4	_aIn Vitro Techniques
650	0	4	_aMale
650	0	4	_aMorphine _xpharmacology
650	0	4	_aMorphine Dependence
650	0	4	_aMuscle, Smooth _xdrug effects
650	0	4	_aNaloxone _xpharmacology
650	0	4	_aNarcotic Antagonists _xpharmacology
650	0	4	_aNarcotics _xpharmacology
650	0	4	_aPhenethylamines _xpharmacology
650	0	4	_aPurinergic P2 Receptor Agonists
650	0	4	_aPurinergic P2 Receptor Antagonists
650	0	4	_aQuinidine _xpharmacology
650	0	4	_aReceptor, Adenosine A1 _xphysiology
650	0	4	_aReceptors, Adenosine A2 _xphysiology
650	0	4	_aReceptors, Purinergic P2 _xphysiology
650	0	4	_aSubstance Withdrawal Syndrome
650	0	4	_aTheobromine _xanalogs & derivatives
650	0	4	_aTheophylline _xanalogs & derivatives
700	1		_aGallo, Chiara
773	0		_tCurrent drug safety _gvol. 4 _gno. 2 _gp. 97-102
856	4	0	_uhttps://doi.org/10.2174/157488609788173035 _zAvailable from publisher's website
999			_c18869456 _d18869456